LABORATORY NEWS
-
Proscia Launches Fifth Generation Of Concentriq, Bringing The Latest Advancements In AI To Pathologists And Scientists
Proscia today introduced the Fifth Generation of its Concentriq[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies.
- Sysmex launches HISCL Platform, Enabling Faster, Scalable Alzheimer's Blood Testing
- Autism Diagnostics Lab Announces The U.S. Launch Of The First Commercial Urine-Based Microbial-Derived Metabolite (MDM™) Gut & Brain Health Test For Autism Screening
- Validated Monospecific Recombinant And Monoclonal Antibodies
- Cizzle Bio Announces Laboratory Validation Of CIZ1B Biomarker Blood Test For Early Lung Cancer At OmniHealth Diagnostics
ARCHIVED NEWSLETTER
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?